Positron Emission Tomography Market Size Projected to Reach USD 5.69 Billion by 2035

According to Precedence Research, the global positron emission tomography size will grow from USD 2.96 billion in 2025 to nearly USD 5.69 billion by 2035, with a healthy CAGR of 6.75% from 2026 to 2035.

The primary drivers of this growth include the increasing prevalence of chronic diseases such as cancer, Alzheimer's, and heart disease, along with advancements in PET technology. The integration of AI and the rise of hybrid imaging systems are expected to enhance diagnostic accuracy, improve patient outcomes, and accelerate the adoption of PET systems worldwide.

Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8151

Market Size and Forecasts:
🔹 Market size in 2025: USD 2.96 Billion
🔹 Market size in 2026: USD 3.16 Billion
🔹 Market size by 2035: USD 5.69 Billion
🔹 CAGR: 6.75% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025

AI's Role in Positron Emission Tomography Market Growth

The integration of Artificial Intelligence (AI), particularly machine learning and deep learning algorithms, has revolutionized the PET industry. By enhancing image quality and enabling more precise diagnostics, AI has reduced scan times and improved the accuracy of disease detection, even in complex cases such as cancer. These AI-powered advancements facilitate faster, more consistent, and accurate image reconstruction, significantly lowering radiation exposure and improving patient safety.

Moreover, AI technologies have enabled the development of automated systems capable of accurately identifying and segmenting lesions, thus reducing observer variability and improving diagnostic consistency across healthcare providers.

🔗 What's Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/positron-emission-tomography-market

Positron Emission Tomography Market Growth Factors

🔹 Rising Chronic Disease Prevalence: The growing incidence of chronic conditions such as cancer and cardiovascular diseases has increased the demand for diagnostic tools like PET scanners that offer superior imaging capabilities for early detection.

🔹 Technological Advancements in Imaging: Innovations like digital PET detectors, including those utilizing silicon photomultiplier tubes, have enhanced image resolution and scanning sensitivity. These developments contribute to the growing demand for next-generation PET systems.

🔹 Increasing Healthcare Investments: Investments in healthcare infrastructure, especially in emerging markets like Asia-Pacific, are driving the adoption of advanced diagnostic technologies, further propelling the PET market growth.

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

Opportunities and Trends in the Positron Emission Tomography Market

The rapid development of hybrid imaging systems combining PET with CT and MRI offers exciting opportunities for growth. These hybrid systems enable comprehensive diagnostics by combining metabolic and anatomical information, enhancing the accuracy of disease detection and improving treatment monitoring.

The neurology segment of the PET market is anticipated to witness significant growth over the forecast period. As new tracers targeting neurological diseases like Alzheimer's are developed, PET is becoming a critical tool for early-stage diagnosis and personalized treatment plans.

🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8151

Regional Insights

🔸 North America Dominated the Market in 2025

North America dominated the market in 2025 due to strong R&D investments and well-established reimbursement systems. The region benefits from early adoption of advanced imaging technologies and serves as a hub for AI-driven diagnostics. High prevalence of chronic diseases and strong collaboration between industry players and research institutions further support market growth.

The U.S. market is expanding with increased applications in neurology and cardiology. Major companies such as GE Healthcare and Siemens are driving innovation through advanced imaging technologies, including high-resolution SiPM detectors. These advancements are making PET imaging more efficient and widely adopted in clinical practice.

🔸 Asia-Pacific Insights

Asia-Pacific is expected to witness the fastest growth due to significant government investments in healthcare infrastructure, particularly in China and India. The rising aging population and increasing cases of chronic diseases are driving demand for advanced diagnostic solutions. Additionally, medical tourism and local manufacturing are boosting regional market expansion.

China's market growth is supported by large-scale infrastructure investments and the emergence of domestic players like United Imaging. The adoption of AI-integrated PET systems and advanced radiotracers is improving diagnostic efficiency and expanding clinical applications, positioning China as a key global market contributor.

🔸 Europe Insights

Europe is expected to grow at a notable rate due to its aging population and rising chronic disease burden. Government initiatives and favorable reimbursement policies are increasing access to PET imaging. Collaborative research efforts are also accelerating the development of advanced diagnostic technologies.

Germany is witnessing growth through innovations in high-resolution imaging technologies and the expansion of outpatient diagnostic services. Supportive reimbursement frameworks are enabling the shift toward non-hospital imaging centers, improving accessibility and efficiency.

🔸 Latin America Insights
Latin America is experiencing significant growth due to increasing healthcare investments and rising demand for advanced diagnostics. The adoption of hybrid imaging systems and AI technologies is modernizing healthcare infrastructure and improving early disease detection.

Brazil is expanding its PET imaging capabilities through increased installations of hybrid systems in urban areas. Investments in radiopharmaceutical production are ensuring a stable supply for diagnostics, supporting the region's transition toward precision medicine.

🔸 Middle East & Africa Insights

The Middle East and Africa are expected to grow steadily due to investments in standalone imaging centers and advanced diagnostic technologies. Public-private partnerships are improving healthcare access and addressing infrastructure challenges, particularly in oncology and neurology diagnostics.

Saudi Arabia is driving regional growth through strong government investments and international collaborations. The adoption of advanced PET imaging systems is enhancing diagnostic accuracy and establishing the region as a key hub for molecular imaging.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8151

Positron Emission Tomography Market Segment Analysis

⬥ Product Analysis

The PET/CT systems segment dominated the market in 2025 due to its ability to combine metabolic and structural imaging, resulting in superior diagnostic accuracy, especially in oncology. These systems enhance operational efficiency and benefit from continuous advancements in high-precision, low-radiation imaging technologies. Their expanding use in cardiology and neurology further strengthens their position as the standard for disease staging and monitoring.

The PET/MRI segment is projected to witness the fastest growth over the forecast period. This growth is driven by high-sensitivity detectors and simultaneous data acquisition, enabling more precise imaging. PET/MRI offers better soft-tissue contrast and significantly reduces radiation exposure, making it highly suitable for pediatric patients and long-term disease monitoring.

⬥ End User Analysis

Hospitals and surgical centers held the largest market share in 2025 due to their ability to manage high patient volumes and support advanced imaging infrastructure. Their access to radiopharmaceuticals, established reimbursement systems, and multidisciplinary diagnostic approaches makes them the primary centers for PET imaging worldwide.

Diagnostic and imaging clinics are expected to grow at the fastest rate between 2026 and 2035. This growth is fueled by the shift toward outpatient care and the adoption of AI-enabled imaging systems. These centers provide faster, more cost-effective diagnostics while improving accessibility and patient throughput, contributing to the expansion of precision medicine.

⬥ Application Analysis

The oncology segment led the market in 2025 due to the increasing global cancer burden. PET imaging plays a critical role in early detection, staging, and treatment monitoring. The integration of PET/CT and PET/MRI technologies allows clinicians to detect metastases earlier and personalize therapies, improving survival rates and treatment efficiency.

The neurology segment is expected to grow rapidly due to advancements in PET/MRI and the development of novel radiopharmaceuticals. These technologies enable early diagnosis and continuous monitoring of neurological disorders. The rising prevalence of diseases like Alzheimer's is further driving the demand for advanced neuroimaging solutions.

Positron Emission Tomography Market Companies and their offerings:

➤ Bracco S.p.A. focuses on PET radiopharmaceuticals, including Fluciclovine 18F for prostate cancer recurrence imaging via PET and licensing radiopharmaceutical therapeutic technologies for oncology. They also provide mobile isotope services for cardiac PET imaging with Rubidium Rb 82 chloride.

➤ Cardinal Health Inc. manufactures, compounds, and distributes PET radiopharmaceuticals like FDG, operating multiple production facilities and nuclear pharmacies for oncology, neurology, and cardiology applications.

➤ Canon Inc. offers digital PET/CT systems such as Celesteion with upgrades like ECG-gated scanning, respiratory gating, and noise reduction techniques (CaLM + PSF, SEMAR), plus Cartesion Prime with AI-enhanced reconstruction (AiCE) for low-dose, high-quality imaging.

➤ CellSight Technologies Inc. develops PET imaging companion diagnostics and tracers like VisAcT for visualizing activated T-cells in immune-oncological therapies, plus reporter gene/PET probe combinations for cell tracking.

➤ GE Healthcare Technologies Inc. provides advanced PET/CT scanners including Discovery series for motion-free imaging, Omni Legend (32 cm FOV) for high sensitivity and resolution, and Omni 128 cm total-body PET/CT for ultra-low dose, fast scans in oncology and beyond.

➤ CMR Naviscan Corp. specializes in high-resolution organ-specific PET systems like Solo II Breast PET scanner and LumaGEM Molecular Breast Imaging for secondary screening and diagnostics.

➤ Jubilant Pharmova Ltd. produces FDG and non-FDG PET radiopharmaceuticals, including PSMA tracers for oncology, cardiology, and neurology, supported by expanding PET manufacturing facilities.

➤ Mediso Ltd. develops preclinical and clinical PET/CT/MRI systems like MultiScan LFER150 (extreme resolution, high sensitivity), nanoScan PET/MRI, and nanoScanPC for quantitative small-animal imaging.

➤ Koninklijke Philips NV manufactures fully digital PET/CT scanners like Vereos with Digital Photon Counting (DPC) technology for superior resolution, sensitivity, quantitative accuracy, and reduced scan times/doses.

➤ MinFound Medical Systems Co. Ltd. offers ScintCare PET/CT systems with digital detectors, low-dose "DosePower" reconstruction, and intelligent quality control for comprehensive clinical applications including radiotherapy positioning.

➤ Neusoft Corp. supplies NeuSight PET-CT scanners (manufactured by Neusoft Medical Systems) with advanced detectors for high sensitivity, spatial resolution, and 4D gating, suitable for cardiology and oncology.

➤ Positron Corp. provides PET-CT systems like NeuSight and Attrius for cardiac and oncology imaging, featuring proprietary IPIE technology, asymmetrical light-guiding, and rental programs for accessibility.

➤ PETsys Electronics SA develops electronics and detector technologies for next-generation PET systems, stemming from Clear-PEM prototypes for high-resolution breast and dedicated PET imaging.

➤ Shimadzu Corp. produces specialized TOF-PET systems like PositView (SET-5002) for head (brain tumors, epilepsy, dementia) and breast exams, offering high sensitivity/resolution without CT radiation.

Segments Covered in the Report

➜ By Product

Standalone PET Systems
PET/CT Systems
PET/MRI Systems

➜ By Application

Oncology
Cardiology
Neurology
Other

➜ By End User

Hospitals and Surgical Centers
Diagnostic and Imaging Clinics
Ambulatory Surgical Centers
Other

➜ By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Looking ahead, the PET market will continue to thrive as AI, hybrid imaging technologies, and total-body PET scanners evolve. The growing demand for personalized care, particularly in oncology and neurology, will drive market growth. Additionally, the expansion of PET imaging into emerging markets will open new avenues for growth, particularly with the adoption of cost-effective, AI-enhanced systems.

The Positron Emission Tomography market is on track for substantial growth, driven by technological advancements, rising healthcare demands, and growing awareness of early disease detection. With a CAGR of 6.75% from 2026 to 2035, the market is set to revolutionize patient care globally, offering significant opportunities for both established players and emerging companies in the healthcare space.

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.